Apoptosis during breast carcinoma progression

Clinical Cancer Research

Volumn 5, Issue 2, 1999, Pages 319-324

  Vakkala, Merja ^b   Lähteenmäki, Kimmo ^b   Raunio, Hannu ^b   Pääkkö, Paavo ^b   Soini, Ylermi ^a,b  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CELL PROLIFERATION; DISEASE COURSE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, NUCLEAR; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM RECURRENCE, LOCAL; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL RATE;

EID: 0345059770     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Reed, J. C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol., 124: 1-6, 1994.
2. Hockenbery, D. M. Bcl-2 in cancer, development and apoptosis. J. Cell Sci., 18: 51-55, 1994.
3. Kerr, J. F. R., Winterford, C. M., and Harmon, B. V. Apoptosis. Its significance in cancer and cancer therapy. Cancer (Phila.), 73: 2013-2026, 1994.
4. White, E. Life, death, and the pursuit of apoptosis. A review. Gene Dev., 19: 1-15, 1996.
5. Yang, E., and Korsmeyer, S. K. Molecular thanatopsis: a discourse on the bcl-2 family and cell death. Blood, 88: 386-401, 1996.
6. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science (Washington DC), 267: 1456-1462, 1995.
7. Cummings, M. C., Winterford, C. M., and Walker, N. I. Apoptosis. Am. J. Surg. Pathol., 2: 88-101, 1997.
8. Fraser, A., and Evan, G. A license to kill. Cell, 85: 781-784. 1996.
9. Rao, L., Perez, D., and White, E. Lamin proteolysis facilitates nuclear events during apoptosis. J. Cell Biol., 135: 1441-1455, 1996.
10. Vaux, D. L., Cory, S., and Adams, T. M. Bcl-2 promotes the survival of haematopoetic cells and cooperates with c-myc to immortalize pre-B cells. Nature (Lond.), 335: 440-442, 1988.
11. Tsujimoto, Y., Cossman, J., Jaffe, E., and Croce, C. Involvement of the bcl-2 gene in human follicular lymphoma. Science (Washington DC), 228: 1440-1443, 1985.
12. Chan, J. K. C., Banks, P. M., Clearly, M. L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, K. C., Grogan, T. M., Harris, N. L., Isaacson, P. G., Jaffe, E. S., Knowles, D. M., Mason, D. Y., Muller-Hermelink, H-K., Pileri, S. A., Piris, M. A., Ralfkiaer, E., Stein, H., and Warnke, R. A. A proposal for classification of lymphoid neoplasms (by the International Lymphoma Study Group). Histopathology, 25: 517-536, 1994.
13. Kluck, R. M., Bossy-Wetzel, E., Green, D. R., and Newmeyer, D. D. The release of cytochrome c from mitochondria: a primary site for bcl-2 regulation of apoptosis. Science (Washington DC), 275: 1132-1136, 1997.
14. L. FEBS Lett., 415: 29-32, 1997.
15. Törmänen, U., Eerola, A-K., Rainio, P., Vähäkangas, K., Soini, Y., Sormunen, R., Bloigu, R., Lehto, V-P., and Pääkkö, P. Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma. Cancer Res., 55: 5595-5602, 1995.
16. Soini, Y., Virkajärvi, N., Lehto, V-P., and Pääkkö, P. Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival. Br. J. Cancer, 73: 1025-1030, 1996.
17. Lipponen, P., Aaltomaa, S., Kosma, V-M., and Syrjänen, K. Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur. J. Cancer, 30A: 2068-2073, 1994.
18. Hellemans, P., van Dam, P. A., Weyler, J., van Oosterom, A. T., Buytaert, P., and Van Marck, E. Prognostic value of bcl-2 expression in invasive breast cancer. Br. J. Cancer, 72: 354-360, 1995.
19. Joensuu, H., Pylkkänen, L., and Toikkanen, S. Bcl-2 protein expression and long term survival in breast cancer. Am. J. Pathol., 145: 1191-1198, 1994.
20. Lipponen, P., Pietiläinen, T., Kosma, V-M., Aaltomaa, S., Eskelinen, M., and Syrjänen, K. Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis. J. Pathol., 177: 49-55, 1995.
21. Bhargava, V., Kell, D. L., van de Rijn, M., and Warnke, R. A. Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Am. J. Pathol., 145: 535-540, 1994.
22. Histological Typing of Breast Tumours, Ed. 2. International Classification of Tumours, No. 2. Geneva: WHO, 1981.
23. Bloom, H. J. G., and Richardson, W. W. Histological grading and prognosis in breast cancer. Br. J. Cancer, 11: 359-377, 1957.
24. Helin, H. J., Helle, M. J., Kallioniemi, O-P., and Isola, J. Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Cancer (Phila.), 63: 1761-1767, 1989.
25. Krajewski, S., Blomqvist, C., Franssila, K., Krajewska, M., Wasenius, V-M., Niskanen, E., Nordling, S., and Reed, J. C. Reduced expression of proapoptotic gene bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res., 55: 4471-4478, 1995.
26. Wang, T. T. Y., and Phang, J. M. Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res., 55: 2487-2489, 1995.
27. Bates, R. C., Lincz, L. F., and Burns, G. F. Involvement of integrins in cell survival. Cancer Metastasis Rev., 14: 191-203, 1995.
28. Pullan, S., Wilson, J., Metcalfe, A., Edwards, G. M., Goberdhan, N., Tilly, J., Hickman, J. A., Dive, C., and Streuli, C. H. Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium. J. Cell Sci., 109: 631-642, 1996.
29. Grasl-Kraupp, B., Ruttkay-Nedecky, B., Koudelka, H., Bukowska, K., Bursch, W., and Schulte-Hermann, R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis and autolytic cell death: a cautionary note. Hepatology, 21: 1465-1468, 1995.
30. Davidson, F. D., Groves, M., and Scaravilli, F. The effects of formalin fixation on the detection of apoptosis in human brain by in situ end-labelling of DNA. Histochem. J., 27: 983-988, 1995.
31. Hawkins, N. J., Lees, J., and Ward, R. L. Detection of apoptosis in colorectal carcinoma by light microscopy and in situ end labelling. Anal. Quant. Cytol. Histol., 19: 227-232, 1997.
32. Gaffney, E. F., O'Neill, A. J., and Stauton, M. J. In situ end-labelling, light microscopic assessment and ultrastructure of apoptosis in lung carcinoma. J. Clin. Pathol., 48: 1017-1021, 1995.